Progyny, Inc. (NASDAQ: PGNY) Stock Competitors & Peer Comparison
See PGNY's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PGNY and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PGNY | $26.61 | +1.22% | 2.1B | 27.43 | $0.97 | N/A |
| UNH | $400.94 | +0.32% | 364.1B | 21.51 | $18.64 | +2.24% |
| CVS | $97.20 | -0.03% | 124B | 12.40 | $7.84 | +2.74% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $414.78 | +2.20% | 89.9B | 14.11 | $29.39 | +1.66% |
| CI | $286.26 | +1.21% | 75.6B | 9.26 | $30.90 | +2.16% |
| HUM | $406.52 | +1.38% | 48.8B | 25.64 | $15.86 | +0.87% |
| CNC | $68.02 | +1.01% | 33.6B | 27.00 | $2.52 | N/A |
| MOH | $202.91 | +0.14% | 10.6B | 29.32 | $6.92 | N/A |
| OSCR | $32.24 | +6.30% | 8.4B | 23.01 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
PGNY vs UNH Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, UNH has a market cap of 364.1B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while UNH trades at $400.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas UNH's P/E ratio is 21.51. In terms of profitability, PGNY's ROE is +0.16%, compared to UNH's ROE of +0.14%. Regarding short-term risk, PGNY is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
PGNY vs CVS Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, CVS has a market cap of 124B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while CVS trades at $97.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas CVS's P/E ratio is 12.40. In terms of profitability, PGNY's ROE is +0.16%, compared to CVS's ROE of +0.06%. Regarding short-term risk, PGNY is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
PGNY vs ANTM Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas ANTM's P/E ratio is 18.99. In terms of profitability, PGNY's ROE is +0.16%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, PGNY is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
PGNY vs ELV Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, ELV has a market cap of 89.9B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while ELV trades at $414.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas ELV's P/E ratio is 14.11. In terms of profitability, PGNY's ROE is +0.16%, compared to ELV's ROE of +0.11%. Regarding short-term risk, PGNY is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ELV's competition here
Cigna Corporation (NYSE: CI)
PGNY vs CI Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, CI has a market cap of 75.6B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while CI trades at $286.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas CI's P/E ratio is 9.26. In terms of profitability, PGNY's ROE is +0.16%, compared to CI's ROE of +0.15%. Regarding short-term risk, PGNY is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CI's competition here
Humana Inc. (NYSE: HUM)
PGNY vs HUM Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, HUM has a market cap of 48.8B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while HUM trades at $406.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas HUM's P/E ratio is 25.64. In terms of profitability, PGNY's ROE is +0.16%, compared to HUM's ROE of +0.07%. Regarding short-term risk, PGNY is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HUM's competition here
Centene Corp. (NYSE: CNC)
PGNY vs CNC Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, CNC has a market cap of 33.6B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while CNC trades at $68.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas CNC's P/E ratio is 27.00. In terms of profitability, PGNY's ROE is +0.16%, compared to CNC's ROE of -0.24%. Regarding short-term risk, PGNY is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
PGNY vs MOH Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, MOH has a market cap of 10.6B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while MOH trades at $202.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas MOH's P/E ratio is 29.32. In terms of profitability, PGNY's ROE is +0.16%, compared to MOH's ROE of -0.00%. Regarding short-term risk, PGNY is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
PGNY vs OSCR Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, OSCR has a market cap of 8.4B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while OSCR trades at $32.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas OSCR's P/E ratio is 23.01. In terms of profitability, PGNY's ROE is +0.16%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, PGNY is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
PGNY vs ALHC Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, ALHC has a market cap of 2.8B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while ALHC trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas ALHC's P/E ratio is 71.29. In terms of profitability, PGNY's ROE is +0.16%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, PGNY is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
PGNY vs CLOV Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, CLOV has a market cap of 2.2B. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while CLOV trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas CLOV's P/E ratio is 99.79. In terms of profitability, PGNY's ROE is +0.16%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, PGNY is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
PGNY vs BHG Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas BHG's P/E ratio is -0.12. In terms of profitability, PGNY's ROE is +0.16%, compared to BHG's ROE of +0.04%. Regarding short-term risk, PGNY is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BHG's competition here
Universal American Corporation (NYSE: UAM)
PGNY vs UAM Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, UAM has a market cap of 0. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas UAM's P/E ratio is 1.01. In terms of profitability, PGNY's ROE is +0.16%, compared to UAM's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check UAM's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
PGNY vs MGLN Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas MGLN's P/E ratio is 8.49. In terms of profitability, PGNY's ROE is +0.16%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, PGNY is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
PGNY vs GTS Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, GTS has a market cap of 0. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas GTS's P/E ratio is 10.41. In terms of profitability, PGNY's ROE is +0.16%, compared to GTS's ROE of +0.07%. Regarding short-term risk, PGNY is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check GTS's competition here
Aetna Inc. (NYSE: AET)
PGNY vs AET Comparison September 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.1B. In comparison, AET has a market cap of 0. Regarding current trading prices, PGNY is priced at $26.61 on the NASDAQ, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 27.43, whereas AET's P/E ratio is 9.57. In terms of profitability, PGNY's ROE is +0.16%, compared to AET's ROE of +0.11%. Regarding short-term risk, PGNY is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check AET's competition here